Want to join the conversation?
$ABBV 2Q15 Call: The acquisition of Pharmacyclics will also drive strong financial benefits, further diversifying our revenue base significantly enhancing our revenue growth. We expect accretion related to the acquisition in excess of $0.60 per share in 2019 ramping to more than a dollar per share in 2021.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?